Literature DB >> 8780584

Human aberrant crypt foci with carcinoma in situ from a patient with sporadic colon cancer.

A K Konstantakos1, I M Siu, T G Pretlow, T A Stellato, T P Pretlow.   

Abstract

Aberrant crypt foci are putative preneoplastic lesions found in the colons of carcinogen-treated rodents and at an increased frequency in humans at increased risk for colon cancer. There is a strong association between aberrant crypt foci and colon cancer, including many shared phenotypic and genetic alterations. The aim of this study is to present further evidence of a relationship between aberrant crypt foci and colon cancer in humans. Multiple aberrant crypt foci from a single patient were identified in unembedded colonic mucosa. Histological sections of the aberrant crypt foci and adjacent mucosa were evaluated for dysplasia, proliferative activity, and pigment-laden macrophages that were characterized with histochemical techniques. The first patient with sporadic colon cancer identified with aberrant crypt foci with carcinoma in situ is described. It is interesting that this 99-year-old patient had multiple carcinomas in situ, pseudomelanosis coli, and two metachronous colon cancers. These data lend support to the hypothesis that aberrant crypt foci are precursors of some colon cancers.

Entities:  

Mesh:

Year:  1996        PMID: 8780584     DOI: 10.1053/gast.1996.v111.pm8780584

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  10 in total

Review 1.  Most effective colon cancer chemopreventive agents in rats: a systematic review of aberrant crypt foci and tumor data, ranked by potency.

Authors:  Denis E Corpet; Sylviane Taché
Journal:  Nutr Cancer       Date:  2002       Impact factor: 2.900

2.  Identification of dysplasia in human colonic aberrant crypt foci.

Authors:  I M Siu; T G Pretlow; S B Amini; T P Pretlow
Journal:  Am J Pathol       Date:  1997-05       Impact factor: 4.307

Review 3.  Aberrant crypt foci in colorectal carcinogenesis. Cell and crypt dynamics.

Authors:  L Roncucci; M Pedroni; F Vaccina; P Benatti; L Marzona; A De Pol
Journal:  Cell Prolif       Date:  2000-02       Impact factor: 6.831

4.  Only fibres promoting a stable butyrate producing colonic ecosystem decrease the rate of aberrant crypt foci in rats.

Authors:  P Perrin; F Pierre; Y Patry; M Champ; M Berreur; G Pradal; F Bornet; K Meflah; J Menanteau
Journal:  Gut       Date:  2001-01       Impact factor: 23.059

5.  Chemoprevention of arylamine-induced colorectal aberrant crypts.

Authors:  Yi Feng; Jason R Neale; Mark A Doll; David W Hein
Journal:  Exp Biol Med (Maywood)       Date:  2008-01

Review 6.  Aberrant crypt foci as microscopic precursors of colorectal cancer.

Authors:  Lei Cheng; Mao-De Lai
Journal:  World J Gastroenterol       Date:  2003-12       Impact factor: 5.742

7.  Aberrant crypt foci: endoscopic assessment and cell kinetics characterization.

Authors:  Pedro Figueiredo; Maria Donato; Marta Urbano; Helena Goulão; Hermano Gouveia; Carlos Sofia; Maximino Leitão; Diniz Freitas
Journal:  Int J Colorectal Dis       Date:  2008-09-04       Impact factor: 2.571

8.  Adiponectin suppresses colorectal carcinogenesis under the high-fat diet condition.

Authors:  T Fujisawa; H Endo; A Tomimoto; M Sugiyama; H Takahashi; S Saito; M Inamori; N Nakajima; M Watanabe; N Kubota; T Yamauchi; T Kadowaki; K Wada; H Nakagama; A Nakajima
Journal:  Gut       Date:  2008-08-01       Impact factor: 23.059

9.  Induction of aberrant crypt foci and flat-type adenocarcinoma in the colons of dogs by N-ethyl-N'-nitro-nitrosoguanidine and their sequential changes.

Authors:  K Sugiyama; Y Oda; K Otori; S Kato; T Hasebe; T Fujii; H Tajiri; H Esumi
Journal:  Jpn J Cancer Res       Date:  1997-10

10.  Caloric restriction reduced 1, 2-dimethylhydrazine-induced aberrant crypt foci and induces the expression of Sirtuins in colonic mucosa of F344 rats.

Authors:  Mariko Tomita
Journal:  J Carcinog       Date:  2012-07-28
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.